Directed Differentiation of Stem Cells into Brown Adipose Tissue

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating Brown Adipose Tissue (BAT) from embryonic stem cells or induced pluripotent stem cells are inefficient and require cell sorting or genetic manipulation, limiting the availability of this therapeutic cell type for metabolic disorders.

Innovation Solution

Directed differentiation of embryonic stem cells or induced pluripotent stem cells into Brown Adipose Tissue (BAT) progenitors and mature BAT cells without the need for cell sorting or genetic manipulation, using specific signaling pathways and media compositions to generate a population of BAT cells that express key markers like UCP-1, with methods that include exposure to HGF, IGF, and FGF signaling pathway activators, as well as BMP inhibitors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If cell sorting or genetic manipulation methods are used to generate BAT from stem cells, then BAT cell purity or specific marker expression can be improved, but the process complexity and time required are increased

Engineering Contradiction:
ImproveBAT cell purityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The differentiation process is divided into distinct sequential stages: mesoderm induction phase, brown adipocyte specification phase, and maturation phase. Each phase uses specific signaling pathway modulators (BMP inhibitors, Wnt inhibitors, PPARγ activators) to guide cells through controlled transitions, achieving pure BAT cells without complex sorting procedures

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The protocol pre-establishes optimal culture conditions and signaling pathway modulations before differentiation begins. By pre-defining the sequence of growth factors and inhibitors to be applied at each stage, the method ensures high BAT cell purity from the outset, eliminating the need for post-differentiation sorting or genetic manipulation

Inventive Principle:
Principle #10Preliminary action

2Manufacturing precision

If cell sorting or genetic manipulation is employed, then BAT cell specificity can be improved, but the production time and cost are increased

Engineering Contradiction:
ImproveBAT cell specificityVSAvoidproduction time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The method systematically varies cultural parameters (growth factor concentrations, inhibitor dosages, medium composition) at each differentiation stage to optimize BAT cell specificity. By adjusting these parameters sequentially—starting with BMP inhibition to specify brown fat lineage, then PPARγ activation for maturation—the protocol achieves high-specificity BAT cells within 2-3 weeks without time-consuming sorting or transfection procedures

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If directed differentiation without cell sorting is used, then the ease of manufacture is improved, but the BAT cell population homogeneity may be reduced

Engineering Contradiction:
Improveease of BAT generationVSAvoidcell population homogeneity
Core Design Contradiction:
Ease of manufactureVSStability of the object's composition

Solution Approach 1:

The differentiation protocol maintains continuous exposure to optimized culture conditions and signaling pathway modulators throughout the 2-3 week process. By continuously providing the appropriate molecular cues (BMP inhibitors, Wnt inhibitors, PPARγ activators) without interruption, the method ensures that all cells in the population undergo uniform differentiation into BAT cells, achieving both ease of manufacture and population homogeneity

Inventive Principle:
Principle #20Continuity of useful action

Data Source

PatentUS11390850B2Generation of brown adipose tissue from pluripotent stem cells in vitro
Publication Date: 2022.07.19 THE BRIGHAM & WOMEN S HOSPITAL INC
  • US11390850B2 patent drawing
  • US11390850B2 patent drawing
  • US11390850B2 patent drawing

AI summary

A population of Brown adipose tissue (BAT) cells generated from embryonic stem cells (ES) or induced pluripotent stem cells (iPS), called iBAT, the use thereof, methods to obtain iBAT by directed differentiation of ES/iPS, and media compositions to obtain iBAT.